Cinctive Capital Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-39,193
Closed -$2.48M 549
2021
Q3
$2.48M Buy
39,193
+29,493
+304% +$2.25M 0.12% 266
2021
Q2
$888K Buy
+9,700
New +$771K 0.04% 376

Other funds holding CDNA

Cinctive Capital Management's CDNA Position: Q4 2021 in Review

Cinctive Capital Management sold out of CareDx (CDNA) in Q4 2021, closing a stake of 39,193 shares — an estimated $2.48M sold.

Cinctive Capital Management first reported a position in CDNA in Q2 2021 and held it in 2 quarters. The position peaked at $2.48M in Q3 2021. 224 funds tracked by Wall St. Rank hold CDNA as of Q4 2021.

  • Cinctive Capital Management reported no remaining CareDx position as of Q4 2021 after selling out during the quarter.
  • Cinctive Capital Management sold 39,193 CareDx shares in Q4 2021, an estimated $2.48M.
  • Cinctive Capital Management first reported a position in CareDx in Q2 2021 and held it in 2 quarters.
  • Cinctive Capital Management's CareDx position peaked at $2.48M in Q3 2021.
  • 224 funds tracked by Wall St. Rank held CareDx as of Q4 2021.

Based on Cinctive Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.